NNACHI MBA: Open Payments
NPI 1649838996 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 34 payments from 7 companies in 2025. Trend: 2023 $482 · 2024 $236 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $383 |
| ABBVIE INC. | 10 | $217 |
| Lundbeck LLC | 3 | $77 |
| Tris Pharma Inc | 3 | $65 |
| Almatica Pharma LLC | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: COBENFY, VRAYLAR, REXULTI, Dyanavel XR, LOREEV XR, CAPLYTA, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
